Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Women's Health - Menopausal Symptoms Drug Pipeline Report' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms Market Open to Takers as Tepid Pipeline Fails to Meet Demand |
Jun 2008 | £2,405 | 90% |
| Hormone Replacement Therapy (HRT) | Sep 2011 | £2,655 | 86% |
| Pipeline and Commercial Insight: Hormonal Replacement Therapy for Menopausal Symptoms Safety fears continue to haunt the market |
Sep 2010 | £9,615 | 81% |
| The World Market for Gynaecology 2007-2017 |
Sep 2007 | £3,200 | 79% |
| Postmenopausal Osteoporosis Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Aug 2011 | £1,265 | 73% |
| Women's Reproductive Disorders Therapeutics 2008-2018 | Sep 2008 | £1,499 | 70% |
| Pipeline Insight: Osteoporosis Bone building drugs become the heart of the pipeline |
Jul 2010 | £7,210 | 59% |
| Mammography World Markets | Mar 2011 | £2,150 | 51% |
- Results 1 - 8 of 8
-
-
- 1
-
-
